Austrian Hypertrophic Cardiomyopathy Registry

Recruiting Observational Study
Hypertrophic Cardiomyopathy
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Medical University of Graz · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The Austrian Hypertrophic Cardiomyopathy (HCM) Registry is a prospective, multicenter registry enrolling patients at multiple outpatient clinics across Austria including academic and non-academic centers. Patients will undergo a structured examination process including assessment for symptoms of HCM, past medical history, concomitant medication, family history and the presence of HCM-specific red …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients admitted to the HCM outpatient clinic of participating centers of the HCM Registry * Interventricular septal thickness ≥ 13 mm and cardiomyopathy-specific red flags OR Interventricular septal thickness ≥ 15 mm not explainable by loading conditions OR Interventricular …
Contacts

Nicolas D Verheyen, MD

004331638530173

nicolas.verheyen@medunigraz.at

CONTACT

Viktoria Santner, MD

004331638531233

viktoria.santner@medunigraz.at

CONTACT